According to Seelos Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.8 M. In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.8 M | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | -100% |
2019 | $0.37 M | |
2018 | N/A | |
2017 | N/A | -100% |
2016 | $0.35 M | -92.64% |
2015 | $4.83 M | -47.74% |
2014 | $9.25 M | 268.74% |
2013 | $2.51 M | -68.78% |
2012 | $8.04 M | 96.1% |
2011 | $4.1 M | -15.77% |
2010 | $4.86 M | 63.72% |
2009 | $2.97 M | -50.08% |
2008 | $5.95 M | 368.96% |
2007 | $1.27 M | -31.95% |
2006 | $1.86 M | -22.18% |
2005 | $2.39 M | 567.6% |
2004 | $0.35 M | 224.51% |
2003 | $0.11 M | -25.19% |
2002 | $0.14 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |